Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
1,071.00
+1.00 (0.09%)
At close: Feb 13, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 91.03 billion as of February 13, 2026. Its market cap has decreased by -13.53% in one year.
Market Cap
91.03B
Enterprise Value
n/a
Revenue
107.87B
Ranking
n/a
PE Ratio
22.57
Stock Price
1,071.00
Market Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 91.03B, an increase of 268.93%. That is a compound annual growth rate of 5.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 91.03B | -6.30% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WITHUS PHARMACEUTICAL Co.,LTD. | 113.27B |
| Pharos iBio | 112.24B |
| Ahn-Gook Pharmaceutical | 100.24B |
| H.PIO | 99.27B |
| Sam-A Pharm. | 98.51B |
| Daehan Nupharm | 93.62B |
| Sinsin Pharmaceutical | 89.96B |
| Polaris AI Pharma | 85.81B |